AI-generated summary
The authors reviewed records of 11 patients with central serous chorioretinopathy treated with low-intensity, high-density subthreshold micropulse laser at one retinal practice. They report improved visual acuity and reduced retinal thickness after treatment, with subretinal fluid resolved in all eyes, and no adverse effects. The study was a small retrospective review without a control group.
- Participants
- 11
- Who or what was studied
- 11 consecutive eyes of 11 patients (9 men, 2 women), aged 30 to 55, with central serous chorioretinopathy
- Limits stated in the abstract
- Small retrospective case series with no control group and variable follow-up of 1 to 45 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.